HIV 2012 : Eleventh International Congress on Drug Therapy in HIV Infection
Call For Papers
The Scientific Committee now invite the submission of abstracts for the Eleventh International Congress on Drug Therapy in HIV Infection. The abstract categories are outlined below.
All accepted abstracts will be published on-line. If the submitted abstract is accepted for presentation, one of the authors on the abstract will be required to register for the congress and present the abstract (either in oral or poster format).
Abstracts are more likely to be considered for oral (as opposed to poster) presentation if they contain new information and clinical rather than non clinical data.
The deadline for the receipt of abstracts is Monday 16 July
Abstract Categories for 2012
Evaluation of ARV Delivery and Coverage
HIV-related Infections, Co-infections and Cancers, etc:
Hepatitis co-infection (HCV and HBV)
Laboratory Monitoring of Disease and Therapy
New Treatments and Targets
Non-AIDS Morbidities and Mortality, and Ageing
Pre- and Post-Exposure Prophylaxis and Treatment as Prevention
Treatment of Children
Treatment of primary infection
Heavily pre-treated patients
Late Breaker Abstracts
Anyone wishing to submit a late breaker abstract should send a letter of intent to: email@example.com by the regular abstract deadline of Monday 16 July addressed to Professor Ian Weller, Chairperson. Only those individuals who have submitted this information and had confirmation of receipt from the Secretariat are permitted to follow with a late-breaker abstract submission. The deadline for the late breaker abstract is Monday 13 August.
Notification of Outcome of Abstract Submission
Abstract submitters will be notified by Friday 14 September of the outcome of their submission. If you have not received an email confirming the outcome by Monday 24 September please contact the congress secretariat at: firstname.lastname@example.org To assist us with the handling of your enquiry it would be helpful if when contacting us you forward a copy of the confirmation email you received when you submitted your abstract so that we can easily trace the outcome of your submission.